Products - Adrenal dysfunction | Topic | NICE

Showing 2 products

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter

Leriglitazone for treating andrenoleukodystrophy [ID3903]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Leriglitazone for treating X-linked andrenoleukodystrophy TS ID 9996
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC